Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Lebedev Lr"'
Autor:
Yu. V. Telegina, I. S. Shchelkunov, T. G. Tereshchenko, Lebedev Lr, V. V. Ermolaev, M. V. Alekseeva, A. Ya. Stolbov, V. P. Klimenko, Yu. S. Alikin
Publikováno v:
Innovations and Food Safety. :69-80
A proposal is being considered for the use of BAS preparations developed in the Institute of medical biotechnology OF the FBU SSC VB «Vector» in the programs of ensuring the country’s security in the field of medicine, veterinary medicine and obt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b1b920700f6440897f76e3ec0df1fec
https://doi.org/10.31677/2311-0651-2019-26-4-69-80
https://doi.org/10.31677/2311-0651-2019-26-4-69-80
Publikováno v:
Russian Journal of Bioorganic Chemistry. 46:342-348
In order to develop a target drug we studied the process of conjugation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) and alendronic acid (ALN). The conjugation reactions were performed both in solution and in the sol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8ac82669141796f4d00bdc1d2c7dc55
https://doi.org/10.1134/s1068162020030073
https://doi.org/10.1134/s1068162020030073
Publikováno v:
Biomeditsinskaya Khimiya. 61:652-656
A novel drug for treatment of bone metastases based on human recombinant tumor necrosis factor (TNF-alpha) has been designed. The drug is a molecular structure containing yeast double-stranded ribonucleic acid (dsRNA) covered by the conjugate of poly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4d94634a8ea7ccaf2f5ae49d8fab901
https://doi.org/10.18097/pbmc20156105652
https://doi.org/10.18097/pbmc20156105652
Autor:
Nadezhda S. Scherbakova, Alexander A. Ilyichev, Larisa I. Karpenko, Anton N. Chikaev, Lyudmila A. Shalamova, Olga G. Pyankova, Olga Yu. Tumanova, Alexander B. Ryzhikov, Lebedev Lr
Publikováno v:
Molecular Immunology. 50:193-199
A major goal in HIV-1 vaccine research is to develop an immunogen that can elicit broadly neutralizing antibodies that efficiently neutralize a wide range of the HIV-1 subtypes. Using biopanning procedure we have selected linear peptide VGAFGSFYRLSVL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36426325860cd4c505bc57689657ad29
https://doi.org/10.1016/j.molimm.2012.01.003
https://doi.org/10.1016/j.molimm.2012.01.003
Autor:
Alexander A. Ilyichev, Bazhan Si, Lebedev Lr, Boris B. Zaitsev, Denis V. Korneev, Larisa I. Karpenko
Publikováno v:
AIDS Research and Human Retroviruses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c281e5777b706e52a0fce48424b09ca
https://doi.org/10.1089/aid.2016.0140
https://doi.org/10.1089/aid.2016.0140
Publikováno v:
Molecular Biology. 44:939-947
Orthopoxviral genomes bear genes for a series of homologous secreted proteins binding tumor necrosis factor (TNF). Orthopoxvirus species have different sets of these proteins. Variola virus has only one protein of this series, CrmB. Although CrmB pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::224abcdce504f0427a22d1d7b16da822
https://doi.org/10.1134/s0026893310060117
https://doi.org/10.1134/s0026893310060117
Autor:
N. I. Akulova, Yu. V. Telegina, G. M. Levagina, Ya. S. Gogina, V. F. Podgornyi, E. A. Volosnikova, V. K. Mikhailova, Lebedev Lr
Publikováno v:
Applied Biochemistry and Microbiology. 46:865-869
Optimization of the stage of fractioning of nucleotide material has been performed, and a technology for purification and obtaining of plasmid DNAs for pharmaceutical purposes has been developed. Plasmid DNAs can be used for construction of DNA vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b491925f0295432c63aac0ca50494c3c
https://doi.org/10.1134/s0003683810090085
https://doi.org/10.1134/s0003683810090085
Autor:
Roman V. Uzhachenko, Alexey Eroshkin, Larisa I. Karpenko, Alexander A. Ilyichev, Bazhan Si, Lebedev Lr, P. A. Belavin
Publikováno v:
Molecular Immunology. 45:661-669
Immunogenic properties of the combined vaccine CombiHIVvac, comprising polyepitope HIV-1 immunogens, one being the artificial polyepitope protein TBI, containing the T- and B-cell epitopes from Env and Gag proteins, and the DNA vaccine construct pcDN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c480c145abe96b19755fc1d76d8cc9
https://doi.org/10.1016/j.molimm.2007.07.016
https://doi.org/10.1016/j.molimm.2007.07.016
Autor:
T. S. Nepomnyashchikh, I. A. Ryazankin, Lebedev Lr, S. G. Pozdnyakov, Sergei N. Shchelkunov, I. P. Gileva
Publikováno v:
Molecular Biology. 39:926-933
PCR was used to amplify DNA fragments containing the genes for interferon γ (IFNγ)-binding proteins (IFNγBPs) of the variola virus (VARV) and monkeypox virus (MPXV). The genes were expressed from baculovirus DNAs in Sf21 insect cells. The recombin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::305986eb23836826704542f4bd4d8aa3
https://doi.org/10.1007/s11008-005-0114-9
https://doi.org/10.1007/s11008-005-0114-9
Autor:
Pustoshilova Nm, Lebedev Lr, I. A. Ryazankin, I. P. Gileva, T. S. Nepomnyashchikh, Totmenin Av, Z. A. Maxutov, Sergei N. Shchelkunov, Afinogenova Gn
Publikováno v:
Molecular Biology. 39:218-225
Genes for TNF-binding proteins (CrmBs) of the variola virus (VARV), monkeypox virus (MPXV) or cowpox virus (CPXV) were isolated by PCR from viral genomes and expressed in a baculovirus system in the Sf21 insect cell line. Properties of the purified r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03d255b9c126257c9caa53b3f0989955
https://doi.org/10.1007/s11008-005-0032-x
https://doi.org/10.1007/s11008-005-0032-x